News | March 15, 2011

Argon Medical Devices Signs Exclusive Vena Cava Filter Agreement

March 15, 2011 – Argon Medical Devices has entered into a definitive license agreement with Rex Medical, for exclusive global rights to market and distribute the Option Retrievable Inferior Vena Cava (IVC) Filter. The filter is an implantable device used in the prevention of pulmonary embolism (PE).

Argon will be exhibiting at the 36th Annual Society of Interventional Radiology (SIR) meeting, to be held in Chicago from March 27-30, 2011.

The nitinol, filter, with a low profile 5 French (6.5 French outer diameter) delivery system, is designed to be implanted into the inferior vena cava of patients to prevent recurrent PE. The filter is designed with symmetric flared struts to direct clot volume into the center of the vessel for maximum dissolution and preservation of blood flow allowing for capture of clinically significant clot and protection against PE. Designed as both a permanent or retrievable implant, the self-centering filter promotes optimal positioning and stability within the inferior vena cava. Its intuitive, easy-to-use design, makes deployment and retrieval safe and effective.

For more information: www.argonmedical.com

Related Content

News | Vena Cava Filters| September 26, 2017
September 26, 2017 — The one-year results of the SENTRY...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
News | January 21, 2015
The number of IVC filters placed has more than doubled in the last 10 years, and by some estimates, less than half of...
Vena Cava Filters, Embolic protection, Pulmonary Embolism, Venous Therapies

Image courtesy of Society of Vascular Surgery

Feature | January 05, 2015
The first large-scale, multispecialty prospective clinical research trial to evaluate the use of inferior vena cava (...
News | August 06, 2014
Decision Resources Group finds that the United States clot management device market will expand through 2022,...
Cook Medical SCAI CIVIC PRESERVE Clincal Studies Vena Cava Filter
News | June 05, 2014
Cook Medical is engaged in two clinical studies that will provide additional data on the safety and effectiveness of...
Argon Medical OptionElite retrievable inferior vena cava (IVC) filter guidewire
Technology | January 23, 2014
Argon Medical Devices Inc. received clearance from the U.S. Food and Drug Administration (FDA) to begin marketing the...
Angiotech Vena Cava Filter
News | April 18, 2013
One venous puncture, rather than two, is a safe and effective approach to intravascular ultrasound-guided inferior vena...
News | April 05, 2013
Continuing its commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism (...
Videos | Vena Cava Filters| July 24, 2012
This video, provided by Crux Biomedical, demonstrates the implantation of the FDA-cleared Crux VCF inferior vena cava
Overlay Init